Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Ann Emerg Med. 2015 Aug 29;67(1):32–39.e3. doi: 10.1016/j.annemergmed.2015.07.495

Table 4.

Outcomes among patients deemed allergic

Variable Metoclopramide + diphenhydramine Metoclopramide + placebo Difference (95%CI)
Improvement in 0–10 pain score between baseline and one hour 3.8 (n=15) 3.7 (n=12)* 0.1 (−2.1, 2.3)
Requirement of Rescue medication 6/15 (40%) 3/14 (21%) 19% (−14, 51%)
Sustained headache freedom1 3/15 (20%) 1/13 (8%) 12% (−13, 37%)
Want same med again2 14/15 (93%) 7/13 (54%) 39% (10, 69%)
*

2 patients did not provide an answer to this question

1

Achieved a headache level of “none” in the ED and maintained a level of “none” without the use of rescue medication for 48 hours. Patients who required rescue medication were considered outcome failures.

2

At the 48 hour follow-up telephone call patients were asked if they wished to receive the same medication during a subsequent migraine visit to the ED.